It has previously been reported that bone-resorbing osteoclasts express VEGF receptors VEGFR1 and R2, and that tumor-derived VEGF (in the presence of RANKL) stimulates osteoclast-mediated bone resorption in vitro [49]. Here, TNFSF11 is linked to neoplasm.